CURX (Curanex Pharmaceuticals Inc Common Stock) Stock Analysis - SEC Filings

Curanex Pharmaceuticals Inc Common Stock (CURX) is a publicly traded the market company. As of May 21, 2026, CURX trades at $0.33 with a market cap of $8.53M and a P/E ratio of -1.91. CURX moved +0.00% today. Year to date, CURX is -9.92%; over the trailing twelve months it is flat. Its 52-week range spans $0.26 to $9.18. Rallies surfaces CURX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find CURX SEC filings?

Rallies organizes CURX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

CURX Key Metrics

Key financial metrics for CURX
MetricValue
Price$0.33
Market Cap$8.53M
P/E Ratio-1.91
EPS$-0.17
Dividend Yield0.00%
52-Week High$9.18
52-Week Low$0.26
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$-4.23M
Gross Margin0.00%

Latest CURX News

CURX Analyst Consensus

CURX analyst coverage data. Average price target: $0.00.

Common questions about CURX

Where can I find CURX SEC filings?
Rallies organizes CURX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show CURX 10-K and 10-Q filings?
Rallies organizes CURX SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is CURX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CURX. It does not provide personalized investment advice.
CURX

CURX